Poster Titles

Room: Independence Ballroom 

Presenting Monday through Thursday

AMO Life Science Co., Ltd.
101.     Synthetic Tumor Microenvironment Based Isolation/Sorting/In Situ Expansion of Heterogeneous Circulating Tumor Cells; Presented by Sangjae L.

102.     Scalable Technology to Identify Diagnostically Relevant Cancer Cells in Blood Samples for Minimal Residual Disease (MRD) Screening Applications of Blood Cancers and Early Stage Lung Cancer; Presented by Rolf M.

Biomatrica, Inc.
103.     Stabilization of HIV RNA on Paper; Presented by Joel D.

Biomatrica, Inc.
104.     The Impact of Preanalytical Variables on Cell-Free DNA and Circulating Tumor Cells; Presented by Amber M.

Future Diagnostics Solutions
105.     A Miniature Bio-Photonics Companion Diagnostics Platform for Reliable Cancer Diagnosis and Treatment Monitoring; Presented by Ernst L.

GeneCapture, Inc.
106.     Novel In Vitro CAPTURE Diagnostic for Point of Care Pathogen Identification; Presented by Paula K.

Genomictree, Inc.
107.     SDC2 Methylation Test by Real-Time PCR in Stool DNA for Early Detection of Colorectal Cancer; Presented by Sungwhan A.

National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
108.     Development of a Point of Care Diagnostic Device for HIV Viral Load Monitoring Using Peptide Nucleic Acids; Presented by Kaylyn O.

Pillar Biosciences, Inc.
109.     Development and Evaluation of a Lung Cancer Fusion NGS Panel; Presented by Dale Y.

Predicine, Inc.
110.     Urine and Blood Based DNA + RNA Liquid Biopsy Tests in Prostate, Bladder and Kidney Cancers; Presented by Shidong J.

RareCyte, Inc.
111.     Novel Multi-Parameter Assays for Investigational Phenotyping of Circulating Tumor Cells; Presented by Tad G.

RareCyte, Inc.
112.     RNA Sequencing of Rare Antigen-Specific T Cells and Tissue Micro-Regions Using the RareCyte Platform; Presented by Lance U.

Sysmex Corporation
113.     Primary Care Immunology Solutions for Chronic Disease Management; Presented by Priyanka A.

Technical University of Denmark
114.     Next Generation of Sepsis Diagnosis; Presented by Peter O.

Thermo Fisher Scientific
115.     Single-Use Technology in the Production of DNA-Free Taq DNA Polymerase; Presented by Samantha L.

Thermo Fisher Scientific
116.     Lyo-Ready SuperScript Reverse Transcriptases: High-Performance Lyophilization-Compatible Enzymes for RT-PCR–Based Assays; Presented by Samantha L.

Thermo Fisher Scientific
117.     Advancing Tools for the Development of Lyophilized qPCR Assays; Presented by Jennifer B.

TriLink BioTechnologies
118.     Single-Cell Small RNA-Seq by Microfluidic Chip Isotachophoresis with sRNA Library Preparation Using Chemically Modified Adapters; Presented by Dick K.

University of Tokyo
119.     Procedure for Non-Coding Region Annotation of NGS Data; Presented by Kotoe K.

University of Toronto
120.     Simplifying Diagnostic Assays with Reagent Tablets; Presented by Buddhisha U. 

Presenting Monday through Tuesday

Seoul National University
201.     Application of Human HbA1c POCT for Canine Diabetes Mellitus; Presented by Yongbaek K.

Stanford University
202.     MicroRNA Isoforms to Classify Breast Cancer Subtypes; Presented by Anna V.

University of Miami
203.     Modular Tissue Engineering of Bone Microenvironment for Propagating Circulating Tumor Cells; Presented by Ashutosh A. 

Presenting Wednesday through Thursday

LIG Biowise Ltd.
301.     Molecular Diagnostics for Detection of Upper-Respiratory Tract Bacterial Pathogens; Presented by Taca V.

National Cheng Kung University
302.     Biomarker Discovery by Proteomics Analysis of Environmental Acidification-Influenced Streptococcus Pyogenes Secretome Involved in Necrotizing Fasciitis; Presented by Pao-Chi L.

National Institute of Standards and Technology
303.     Predicting Rates of Cell State Change Due to Stochastic Fluctuations Using a Data-Driven Landscape Model; Presented by Anne P.

SerImmune, Inc.
304.     Polyplex Infectious Disease Serology Enabled by Antibody Epitope Repertoire Sequencing; Presented by Steve K.

Viracor Eurofins Clinical Diagnostics
305.     A Novel Whole-Gene 16S rRNA Next-Generation Sequencing Assay for Identification of Bacterial Meningitis Pathogens and Comparison of a De Novo Assembler-Based Analysis Method to a Multiple Reference Sequence Mapping-Based Analysis Method; Presented by Scott C.